Views & Analysis "Fake news" and credibility in medical publishing Natalie Yeadon looks at how the industry can help healthcare professionals, patients, and their families combat false and misleading scientific information.
News Ipsen charts $1.75bn course for Kartos acquisition Ipsen has agreed to buy cancer biotech Kartos Therapeutics for $450m upfront, adding a late-stage drug in the challenging MDM2 inhibitor class.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.